Determining liver fat content with MRT scans to analyze the effect of liver activity on the basal metabolic rate - Liver-MRT

ehrstuhl für Molekulare Ernährungsmedizin0 个研究点目标入组 32 人开始时间: 2017年12月29日最近更新: 2024年8月19日

试验速览

暂无简介。

•missing consent form,
•active smoker,
•chronic diseases: chronic infection (e.g. HIV), liver diseases (e.g. HBV, HCV); diabetes mellitus; untreated endocrinologic diseases (e.g. thyrotoxicosis or hypothyroidism); autoimmune disease; heart attack, heart disease, cancer or stroke within the last three years; pacemaker; high blood pressure (>150/95 mmHg); circulatory disorder; kidney dialysis; chronic lung disease; gastric ulcer; Parkinson's disease; severe psychological or neurological disorder within the last three years; blood transfusion; outpatient care; unintended weight loss (>5% in the last three months);
•Contraindication for MRT: pacemaker; implanted defibrillator; artificial cardiac valve; cardioseal; aneurisma-clips (not MR compatible); implanted magnetic metal part;cochlear implant; metal shiver; shell splinter; acupuncture needle; insulin pump; piercings (non removeable); lung diseases; diseases with the central nervous system; pregnant or breast feeding women; claustrophobia; active participation at other medical trials

发起方

ehrstuhl für Molekulare Ernährungsmedizin